Karl S. Dahlquist - May 1, 2023 Form 4 Insider Report for AtriCure, Inc. (ATRC)

Signature
/s/ Karl S. Dahlquist
Stock symbol
ATRC
Transactions as of
May 1, 2023
Transactions value $
-$198,014
Form type
4
Date filed
5/3/2023, 04:03 PM
Previous filing
Mar 3, 2023
Next filing
Jun 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRC Common Stock Sale -$198K -4.42K -10.84% $44.83 36.3K May 1, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These shares were sold pursuant to a 10b5-1 trading plan adopted on February 24, 2023.
F2 This transaction was executed in multiple trades at prices ranging from $44.31 to $45.45 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.